Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1024713

registered interest
date	13/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the number of patients waiting at least three weeks to see a GP.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	202044
answer	answer is ministerial correction date of answer 18/12/2018 answer text <p>The Government has committed to ensuring everyone across the country has easier and more convenient access to general practice services, including appointments in the evenings and weekends.</p><p> </p><p>The latest National Health Service planning guidance, issued by NHS England in February 2018, brought forward the deadline for clinical commissioning groups to provide extended access to general practice services to 1 October 2018, to ensure additional capacity is in place ahead of winter 2018. This includes ensuring that access is available during peak times of demand, including bank holidays and across the Easter, Christmas and New Year periods.</p><p> </p><p>NHS England and Health Education England (HEE) are working together with the profession to increase the general practitioner (GP) workforce. This includes measures to boost recruitment, address the reasons why GPs are leaving the profession, and encourage GPs to return to practice.</p><p> </p><p>The number of doctors entering GP speciality training has been increasing year on year, this year HEE recruited the highest number of GP trainees ever - 3,473 GP trainees against a target of 3,250, a 10% increase on last year.</p><p> </p><p>Greater skill mix is also key to releasing capacity in general practice, we have committed to investment in the multidisciplinary workforce in general practice. As of June 2018, there were</p><p>over 3,300 additional clinical staff, excluding GPs, working in general practice since 2015; consisting of over 500 more nurses and 2,800 more other direct patient care.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/12/2018 17:06:19 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

1024789

registered interest
date	13/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer: Staffordshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) increase early diagnosis rates for ovarian cancer and (b) increase access to treatment for ovarian cancer in specialist centres in Staffordshire.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	202081
answer	answer is ministerial correction date of answer 18/12/2018 answer text <p>Public Health England (PHE) has run a number of ‘Be Clear on Cancer’ campaigns to help improve early detection of cancer including ovarian cancer. In 2014 PHE ran a pilot regional ovarian cancer campaign in the North West of England. In 2017, PHE ran a pilot campaign in the East and West Midlands which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of a number of cancers, including ovarian cancer. NHS England has invested over £200 million between 2017 and 2019, supporting Cancer Alliances to accelerate diagnosis and enhance quality of life.</p><p> </p><p>Staffordshire clinical commissioning groups commission diagnostic services for ovarian cancer fully in line with National Institute for Health and Care Excellence guidelines across the whole sustainability and transformation partnership.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/12/2018 17:04:54 answering member 4067 label Biography information for Steve Brine
tabling member	1436 label Biography information for Paul Farrelly

1024805

registered interest
date	13/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has set a target for reducing the number of deaths due to smoking-related conditions in the lifetime of this Parliament.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	202051
answer	answer is ministerial correction date of answer 18/12/2018 answer text <p>The Government has not set a target for reducing the number of deaths due to smoking related conditions. Last year we published ‘Towards a smoke-free generation: a Tobacco Control Plan for England’, which committed the Government to achieve a smoke-free generation. Over the course of this Parliament the Government aims to reduce smoking prevalence from:</p><p>- 15.5% to 12% amongst adults;</p><p>- 10.7% to 6% amongst pregnant women; and</p><p>- 8% to 3% amongst 15-year olds who regularly smoke.</p><p> </p><p>The Government also aims to reduce the inequality gap in smoking prevalence between those in routine and manual occupations and the general population.</p><p> </p><p>Death rates due to smoking have been falling since 2006 and evidence suggests that quitting smoking will improve one’s life expectancy, even if quitting happens later in life.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/12/2018 17:01:16 answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell

1024019

registered interest
date	12/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Life Expectancy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of regional disparities on life expectancy.
tabling member constituency	Blackburn
tabling member printed	Kate Hollern
uin	201724
answer	answer is ministerial correction date of answer 17/12/2018 answer text <p>Public Health England has published ‘A review of recent trends in mortality in England’. This shows that life expectancy is as high as it has ever been in this country, but improvements have slowed down, and there remain differences in life expectancy between areas across the country. The review is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/recent-trends-in-mortality-in-england-review-and-data-packs" target="_blank">https://www.gov.uk/government/publications/recent-trends-in-mortality-in-england-review-and-data-packs</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/12/2018 17:45:31 answering member 4067 label Biography information for Steve Brine
tabling member	4363 label Biography information for Kate Hollern

1023180

registered interest
date	11/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to ensure that children are protected from the marketing of alcohol products.
tabling member constituency	Congleton
tabling member printed	Fiona Bruce
uin	201158
answer	answer is ministerial correction date of answer 17/12/2018 answer text <p>The Government is committed to working with industry to address concerns over any irresponsible promotions, advertising and marketing relating to alcohol, particularly to ensure that children and young people are suitably protected. Advertising in the United Kingdom is regulated by the Advertising Standards Authority, the industry’s independent regulator, who enforces the Advertising Codes through a system of self-regulation and co-regulation with Ofcom. The Codes apply to all media, including broadcast and online, and set standards for accuracy and honesty to which advertisers are expected to adhere, including specific conditions on advertising to children, causing offence and social responsibility. The Codes currently state that alcohol advertising must not be targeted at people under 18 and “should not imply, condone or encourage immoderate, irresponsible or anti-social drinking.&quot;</p><p> </p><p>The Codes are regularly reviewed and updated to ensure they remain effective. The Portman Group also provides a Code to the alcohol industry on Naming and Packaging and Promotion of Alcoholic Drinks, which includes that drinks should not have a particular appeal to under-18s.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/12/2018 17:44:46 answering member 4067 label Biography information for Steve Brine
tabling member	3958 label Biography information for Fiona Bruce

1023291

registered interest
date	11/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment has been made of the appropriateness of the Single Technology Appraisal process for rare diseases that do not meet the Highly Specialised Technology criteria.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	201198
answer	answer is ministerial correction date of answer 17/12/2018 answer text <p>All topics, including selected drugs for rare diseases, are considered through a rigorous topic selection process before formal referral to the National Institute for Health and Care Excellence (NICE) to ensure that NICE guidance is appropriate and will add value. NICE assesses most significant new drugs through its technology appraisal programme through which it has been able to recommend a number of drugs licenced for the treatment of rare diseases for routine use on the National Health Service.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/12/2018 17:43:30 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

1023292

registered interest
date	11/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many rare disease treatments appraised through the Single Technology Appraisal process have been approved by NICE.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	201199
answer	answer is ministerial correction date of answer 17/12/2018 answer text <p>The National Institute for Health and Care Excellence has advised that it has published 48 technology appraisals of orphan medicines of which it has recommended 75% for some or all of the eligible patient population.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/12/2018 17:44:06 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

1023293

registered interest
date	11/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps are being taken to reduce variations in access to rare disease medicines in England, Wales, Scotland and Northern Ireland.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	201200
answer	answer is ministerial correction date of answer 17/12/2018 answer text <p>All issues relating to healthcare provisions are matters for the devolved administrations.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) makes recommendations on whether selected medicines for rare diseases and other treatments should be routinely funded by the National Health Service in England through its technology appraisal and highly specialised technologies programmes.</p><p> </p><p>NHS commissioners in England are legally required to fund drugs and treatments recommended by NICE to ensure consistent access across England. In the absence of NICE guidance on a treatment, commissioning decisions are made locally by individual clinical commissioning groups (CCGs). CCGs make funding decisions based on the needs of their population. Commissioning is about getting the best possible health outcomes for the local population and this involves assessing local needs and deciding priorities and strategies.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/12/2018 17:46:54 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

1023324

registered interest
date	11/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 3 December 2018 to Question 195079 on Pneumococcal Diseases: Vaccination, whether the modelling paper used by Public Health England to support the Joint Committee on Vaccination and Immunisation in its advice on the pneumococcal vaccination programme will be (a) made publicly available and (b) reviewed by external experts in advance of any ministerial decision being made on a change to the pneumococcal vaccination schedule.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	201209
answer	answer is ministerial correction date of answer 17/12/2018 answer text <p>Modelling prepared by Public Health England supported the Joint Committee on Vaccination and Immunisation’s advice to move to a 1+1 schedule for Pneumococcal Conjugate Vaccine and outlines the expected impact of the change. This model has been submitted for publication in a peer reviewed journal, and will be published in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 201210 question first answered 17/12/2018 17:46:17 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth

1023325

registered interest
date	11/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 24 October 2018 to Question 180205 on Pneumococcal Diseases: Vaccination, whether the expected number of cases of pneumococcal disease following the advice to change the vaccination schedule will be (a) made publicly available, (b) communicated to patient groups and (c) open to peer review in advance of any ministerial decision being made on a change to the pneumococcal vaccination schedule.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	201210
answer	answer is ministerial correction date of answer 17/12/2018 answer text <p>Modelling prepared by Public Health England supported the Joint Committee on Vaccination and Immunisation’s advice to move to a 1+1 schedule for Pneumococcal Conjugate Vaccine and outlines the expected impact of the change. This model has been submitted for publication in a peer reviewed journal, and will be published in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 201209 question first answered 17/12/2018 17:46:17 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth